Skip to main content
OpenTrials
Completed

NCT Number: NCT06517329

Bullying Experiences Among Alexandria Faculty of Medicine Students

A cross-sectional study was conducted at Faculty of Medicine, Alexandria to study the prevalence, types and consequences of bullying among medical students. An online survey was distributed among medical students. The data collection continued for two academic years: 2021-2022 and 2022-2023.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine Alexandria University

Alexandria, Egypt

About this study

A survey based Study was implemented. Questionnaire was used to collect sociodemographic data, exposure to different types if bullying, response and consequences of bullying

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • medical students enrolled at undergraduate or graduate programs of Faculty of medicine who were exposed to bullying

Exclusion criteria

  • medical students who were not exposed to hullying

Treatment and study plan

Primary outcomes

  1. Prevalence

    Time frame: 2021-2023

    Percentage of Students exposed to bullying

Sponsors and collaborators

Lead sponsor

Alexandria University

Other

Registry information

Official study title

From Scrubs to Scars: Understanding Bullying Experiences Among Alexandria Faculty of Medicine Students

Important dates

Study start
2021
Primary completion
2023
Study completion
2024
First posted
Jul 24, 2024
Registry last updated
Jul 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.